Camille C. Gunderson

Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study

Dmitriy Zamarin, Robert A. Burger, Michael W. Sill et al. · Journal of Clinical Oncology · 2020 · 329 citations · Full text

The impact of obesity on surgical staging, complications, and survival with uterine cancer: A Gynecologic Oncology Group LAP2 ancillary data study

Camille C. Gunderson, James Java, Kathleen N. Moore et al. · Gynecologic Oncology · 2014 · 120 citations

Obesity, Gynecologic Surgery, Surgical Oncology +14

A contemporary analysis of epidemiology and management of vaginal intraepithelial neoplasia

Camille C. Gunderson, Elizabeth Nugent, Stacie H. Elfrink et al. · American Journal of Obstetrics and Gynecology · 2013 · 116 citations

Vulvar Diseases, Cervical Cancer, Gynecological Surgery +9

A phase 1b dose escalation study of ipafricept (OMP 54F28) in combination with paclitaxel and carboplatin in patients with recurrent platinum-sensitive ovarian cancer

Kathleen N. Moore, Camille C. Gunderson, Paul Sabbatini et al. · Gynecologic Oncology · 2019 · 102 citations · Full text

Phase 1B, Omp 54F28, Oncology +8

Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis

Amanda N. Fader, James Java, Meaghan Tenney et al. · Gynecologic Oncology · 2016 · 99 citations · Full text

Gynecologic Surgery, Surgical Oncology, Tumoral Pathology +9